1. Search Result

Search Result

Targets Recommended: NEDD8-activating Enzyme

Results for "847499-27-8" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-10454


    Proteasome NF-κB Apoptosis Cancer
    Delanzomib (CEP-18770) is a potent and orally active chymotrypsin-like activity of the proteasome inhibitor with an IC50 of 3.8 nM. Delanzomib inhibits NF-κB activity, induces cancer cell apoptotic, and has strong antiangiogenic and anti-cancer activities.